Multistate modeling for survival analysis in critically ill patients treated with meropenem.

Peng, Yaru; Minichmayr, Iris K; Liu, Han; Xie, Feifan; Friberg, Lena E

Peng, Yaru; Minichmayr, Iris K; Liu, Han; Xie, Feifan; Friberg, Lena E.

Afiliação

Peng Y; Department of Pharmacy, Uppsala University, Uppsala, Sweden.
Minichmayr IK; Division of Biopharmaceutics and Pharmacokinetics, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, China.
Liu H; Department of Pharmacy, Uppsala University, Uppsala, Sweden.
Xie F; Department of Clinical Pharmacology, Medical University Vienna, Vienna, Austria.
Friberg LE; Department of Pharmacy, Uppsala University, Uppsala, Sweden.

CPT Pharmacometrics Syst Pharmacol ; 13(2): 222-233, 2024 Feb.

Article em En | MEDLINE | ID: mdl-37881115

Assuntos

Antibacterianos; Estado Terminal; Humanos; Meropeném/farmacologia; Estado Terminal/terapia; Testes de Sensibilidade Microbiana

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Estado Terminal / Antibacterianos Limite: Humans Idioma: En Revista: CPT Pharmacometrics Syst Pharmacol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Suécia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google